Arrowhead Pharmaceuticals, Inc. (ARWR) financial statements (2020 and earlier)

Company profile

Business Address 225 SOUTH LAKE AVENUE
PASADENA, CA 91101
State of Incorp. DE
Fiscal Year End September 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
9/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2597766859915428
Cash and cash equivalents2223025858113319
Short-term investments374641 18229
Receivables1000  0
Prepaid expense311131 
Prepaid expense and other current assets1
Other current assets311410 
Other undisclosed current assets      0
Total current assets:26579689110315529
Noncurrent Assets
Property, plant and equipment23141615544
Long-term investments and receivables44    232
Long-term investments44    232
Intangible assets, net (including goodwill)171920222513
Intangible assets, net (excluding goodwill)171920222513
Other noncurrent assets0000   
Prepaid expense and other noncurrent assets5
Other undisclosed noncurrent assets    00(5)
Total noncurrent assets:8533363829288
TOTAL ASSETS:35011210412813218337
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities191212211473
Accounts payable83412531
Accrued liabilities7555511
Employee-related liabilities5434431
Deferred revenue78
Debt 000001
Deferred rent credit00
Derivative instruments and hedges, liabilities  12144
Deferred revenue and credits63000
Other liabilities0000001
Other undisclosed current liabilities 0     
Total current liabilities:9712192616129
Noncurrent Liabilities
Long-term debt and lease obligation 223111
Long-term debt, excluding current maturities 223  0
Capital lease obligations   111
Liabilities, other than long-term debt9225002
Deferred revenue and credits25   
Deferred revenue5
Deferred rent credit42
Other liabilities 000002
Other undisclosed noncurrent liabilities    64 
Total noncurrent liabilities:9448753
Total liabilities:106162333231712
Stockholders' equity
Stockholders' equity attributable to parent24596819611016727
Preferred stock   0000
Common stock0000000
Additional paid in capital664583514494427391194
Accumulated other comprehensive income (loss)(0)(0)00(0)  
Accumulated deficit(419)(487)(433)(398)(317)(225)(166)
Stockholders' equity attributable to noncontrolling interest(1)(1)(1)(1)(1)(1)(2)
Total stockholders' equity:24495819511016626
TOTAL LIABILITIES AND EQUITY:35011210412813218337

Income statement (P&L) ($ in millions)

9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
9/30/2013
Revenues16916310000
Cost of revenue
(Cost of Goods and Services Sold)
      (0)
Gross profit:16916310000
Operating expenses(108)(72)(68)(82)(96)(53)(25)
Other undisclosed operating income      0
Operating income (loss):61(56)(37)(82)(96)(53)(25)
Nonoperating income (expense)71304(5)(7)
Investment income, nonoperating(1)   (1)  
Other nonoperating income (expense) 01000(1)
Interest and debt expense     (0) 
Income (loss) from continuing operations before equity method investments, income taxes:68(54)(34)(82)(92)(59)(32)
Loss from equity method investments     (0)(1)
Other undisclosed income from continuing operations before income taxes     01
Income (loss) from continuing operations before income taxes:68(54)(34)(82)(92)(59)(32)
Income tax expense(0)(0)(0)(0)(0)(0) 
Income (loss) from continuing operations:68(54)(34)(82)(92)(59)(32)
Loss from discontinued operations      (0)
Net income (loss):68(54)(34)(82)(92)(59)(32)
Net income attributable to noncontrolling interest     01
Net income (loss) available to common stockholders, diluted:68(54)(34)(82)(92)(59)(31)

Comprehensive Income ($ in millions)

9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
9/30/2013
Net income (loss):68(54)(34)(82)(92)(59)(32)
Comprehensive income (loss):68(54)(34)(82)(92)(59)(32)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest     0(1)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)(0)00(0)  
Comprehensive income (loss), net of tax, attributable to parent:68(55)(34)(82)(92)(59)(32)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: